HOME

“Our VASCERN project aims to facilitate and improve diagnosis, treatment and care for ALL patients suffering from Rare Multisystemic Vascular Diseases, thus enhancing access to care, and improving quantity and quality of life of these patients.
Networking, sharing and spreading our expertise, promoting best practices, guidelines and clinical outcomes, patient-empowerment, improving knowledge through clinical and basic research are among our objectives.”

Prof. Guillaume Jondeau, Network Coordinator

All you need to know about ERNs

Last News

  • VASCERNdays2017: Success of our First Annual Seminar!

    VASCERNdays2017: Success of our First Annual Seminar!

    More than 80 participants gathered during the VASCERN days 2017, our 1st 2 days Annual Seminar, which took place in Paris …

    Oct 31, 2017 0

    enabled
  • VASCERN is now on Facebook!

    VASCERN is now on Facebook!

    The VASCERN coordination team is very happy to announce that we now have an official Facebook page!

    As planned in our 1st year …

    Oct 31, 2017 0

    enabled
  • VASCERN YouTube Channel is launched

    VASCERN YouTube Channel is launched

    The  availability of conferences on YouTube via the VASCERN YouTube Channel is part of our first year action plan (Work …

    Oct 31, 2017 0

    enabled
  • Health in the digital society, Message from EU Commissioner for Health

    Health in the digital society, Message from EU Commissioner for Health

    ‘Health in the digital society’ conference, Tallinn, 17 October 2017
    Message from Vytenis Andriukaitis, European Commissioner for Health and Food Safety
    “The …

    Oct 29, 2017 0

    enabled
  • Rare Barometer Voice: make your voice heard on Rare Disease Research

    Rare Barometer Voice: make your voice heard on Rare Disease Research

    Rare Barometer Voice is a EURORDIS initiative.
    “Rare Barometer Voices is a community of people living with a rare disease who …

    Oct 24, 2017 0

    enabled
  • Report: 5th International Summer School on Rare Disease Registries

    Report: 5th International Summer School on Rare Disease Registries

    Read the Report from RD-Connect of the Rare Diseases Registries Summer School, which took place in Rome in September.

    VASCERN was …

    Oct 18, 2017 0

    enabled
  • VASCERN 1st Annual Seminar, Paris, October 13-14

    VASCERN 1st Annual Seminar, Paris, October 13-14

    The VASCERN 1st annual seminar will take place in Paris on October 13-14! This event will gather 80 participants, including …

    Oct 2, 2017 0

    enabled
  • VASCERN Coordination Team is growing!

    VASCERN Coordination Team is growing!

    The Project coordination team based in Paris (Healthcare Provider Coordinating: Assistance Publique Hôpitaux de Paris, Hospital Bichat – Center of …

    Oct 2, 2017 0

    enabled
  • VASCERN Mobile APP

    VASCERN Mobile APP

    Set up a VASCERN free Mobile Application for IOS and Android, which will enable patients and doctors to find & …

    Sep 29, 2017 0

    enabled
  • EU Commissioner for Health on ERNs

    EU Commissioner for Health on ERNs

    At the occasion of the 18th European Day for Organ Donation and Transplantation, Vytenis Andriukaitis, EU Commissioner for Health and …

    Sep 11, 2017 0

    enabled
  • Dutch Lymphedema Guidelines

    Dutch Lymphedema Guidelines

    Read the new article on the Dutch Lymphedema guidelines by our Pediatric and Primary Lymphedema Chair, Dr Robert Damstra (the …

    Sep 4, 2017 0

    enabled
  • New HHT-WG Publication

    New HHT-WG Publication

    A new scientific publication by Dr Sophie Dupuis-Girod, HHT-WG Co-chair and Dr Claire Shovlin, HHT-WG Chair, has been published:

    The Lung …

    Sep 4, 2017 0

    enabled
  • VASCERN Meetings

    VASCERN Meetings

    VASCERN five Rare Diseases Working Groups (Hereditary Haemorrhagic Telangiectasia (HHT-WG), Heritable Thoracic Aortic Diseases (HTAD-WG), Medium Sized Arteries (vascular Ehlers …

    Jul 28, 2017 0

    enabled
  • VASCA-WG new scientific publication

    VASCA-WG new scientific publication

    A novel blood vessel disorder and its genetic cause discovered

    Researchers in the group of Prof M. Vikkula of the de …

    Jul 28, 2017 0

    enabled
  • EU Consultation on eHealth

    EU Consultation on eHealth

    The European Commission has launched a open consultation on digital transformation of health and care.

    Cross-border access to and management …

    Jul 28, 2017 0

    enabled
  • ERNs new videos

    ERNs new videos

    The European Commission has released four new video testimonials from rare diseases patients, explaining how European Reference Networks for Rare …

    Jul 28, 2017 0

    enabled
  • ERNs Clinical Patient Management System

    ERNs Clinical Patient Management System

    A training version of the Clinical Patient Management System for European Reference Networks on Rare Diseases has been released by …

    Jul 25, 2017 0

    enabled
  • VASCERN ePAG meeting in Budapest

    VASCERN ePAG meeting in Budapest

    During the EURORDIS Membership Meeting in Budapest on May 19 – 20, some of our VASCERN ePAG (European Patient Advocacy Group) representatives had …

    May 31, 2017 0

    enabled
  • eHealth Call for ERNs

    eHealth Call for ERNs

    The European Commission (INEA Agency) has launched a Connecting Europe Facility (CEF) Telecom Call on eHealth for European Reference Networks …

    May 31, 2017 0

    enabled
  • Members Area available!

    Members Area available!

    VASCERN Members are invited to create a EU login and access the VASCERN Collaborative IT Platform

    Apr 28, 2017 0

    enabled
LogoOnly

VASCERN, the European Reference Network on Rare Multisystemic Vascular Diseases gathers 31 highly specialized multidisciplinary Healthcare Providers (HCPs) from 11 EU Member States in this area of expertise. VASCERN is coordinated by Prof. Guillaume Jondeau, Cardiologist and Coordinator of the Center of Reference for Marfan Syndrome and related disorders, AP-HP Hôpital Bichat, Paris, France.

VASCERN includes five Rare Diseases Working Groups: Hereditary Haemorrhagic Telangiectasia (HHT-WG), Heritable Thoracic Aortic Diseases (HTAD-WG), Medium Sized Arteries (vascular Ehlers Danlos Syndrome) (MSA-WG), Pediatric and Primary Lymphedema (PPL-WG), Vascular Anomalies (VASCA-WG). This scope will enlarge to include all Rare Multisystemic Vascular Diseases. The specific Patient-WG enables Patient representatives to work on common issues and to be involved in all activities. In addition, several Thematic Working Groups are established to better tackle transversal work packages on: communication, eHealth, ethics, patient registry, and training & education.

All our HCP Members are Centers of Reference/Excellence recognized in their countries. These HCP have developed extensive European collaborations through their specific Rare Diseases’ networks. They joined this ERN to foster and reinforce European cooperation in Rare Multisystemic Vascular Diseases, following a common and multidisciplinary approach to patient care, in order to overcome the challenges of rarity.

They are committed to improve diagnosis, treatment, and care for and with patients by using all opportunities and activities, which can be offered by VASCERN.

Find out all information about our Network

LogoOnly

The first European Reference Networks (ERNs) on Rare Diseases have been approved in December 2016, following the first ERN Call for proposal (European Commission, DG Health, March 2016) and will be launched officially in March 2017 in Vilnius.

Among 24 ERNs, the European Reference Network on Rare Multisystemic Vascular Diseases, VASCERN, has been validated and successfully received the ERN label.

The ERNs aim to facilitate and improve access to diagnosis and treatment in rare or low prevalence complex diseases or conditions by pooling existing highly specialised Healthcare Providers/Centers of Excellence across the EU. They will share knowledge, experience, medical research, teaching, training, resources and use relevant communication and eHealth tools to make expertise travel rather than the patients. This will also reduce inequalities of treatment within the EU.

Find out all information about the ERNs here

ERN_Banner_European_Commission_V2